More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis published in BMC Medicine.

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Scientists found that obesity may exist in 11 biological forms, each linked to different genes and body functions.

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

Findings reveal that the health of children in the U.S. has deteriorated across nearly every major health indicator over the ...

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global ...

The MC4R agonist targets rare genetic and hypothalamic obesity, with potential as a combination or maintenance therapy for general obesity alongside GLP-1 agents.

India’s growing obesity epidemic, especially among youth, poses a major public health risk. Here’s why preventive healthcare ...

Hengrui Pharma and Kailera Therapeutics have reported positive topline data from the former’s Phase III trial (HRS9531-301) ...